CD79A and infection: The function of plasma IgA antibodies against SARS-CoV-2 is uncertain because they may not reach infection sites in the respiratory tract and IgA lacks IgG’s effector function in antibody-dependent cellular cytotoxicity and complement activation (42), although serum IgA levels in Covid-19 patients correlated with neutralizing capacity (13).